Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX)

11 filings reported holding PTIX - Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share as of Q3 2024.
Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 165K shares of 870K outstanding shares and own 18.98% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (40.9K shares), VANGUARD GROUP INC (33.2K shares), GEODE CAPITAL MANAGEMENT, LLC (26.1K shares), OSAIC HOLDINGS, INC. (21.4K shares), STATE STREET CORP (13.8K shares), Virtu Financial LLC (13.1K shares), UBS Group AG (9.74K shares), Tower Research Capital LLC (TRC) (6.83K shares), BANK OF AMERICA CORP /DE/ (41 shares), and FNY Investment Advisers, LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.